Literature DB >> 23076209

ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.

Nir Ben-Chetrit1, Gabi Tarcic, Yosef Yarden.   

Abstract

Unlike the well-characterized checkpoints of the cell cycle, which establish commitment to cell division, signaling pathways and gene expression programs that commit cells to migration are incompletely understood. Apparently, several molecular switches are activated in response to an extracellular cue, such as the epidermal growth factor (EGF), and they simultaneously confer distinct features of an integrated motile phenotype. Here we review such early (transcription-independent) and late switches, in light of a novel ERK-ERF-EGR1 switch we recently reported in the FASEB Journal. The study employed human mammary cells and two stimuli: EGF, which induced mammary cell migration, and serum factors, which stimulated cell growth. By contrasting the underlying pathways we unveiled a cascade that allows the active form of the ERK mitogen-activated protein kinase (MAPK) cascade to export the ERF repressor from the nucleus, thereby permitting tightly balanced stimulation of an EGR1-centered gene expression program.

Entities:  

Year:  2012        PMID: 23076209      PMCID: PMC3544783          DOI: 10.4161/cam.22263

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  40 in total

1.  Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.

Authors:  L Le Gallic; D Sgouras; G Beal; G Mavrothalassitis
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

Review 2.  Tensin.

Authors:  Su Hao Lo
Journal:  Int J Biochem Cell Biol       Date:  2004-01       Impact factor: 5.085

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 5.  Life at the leading edge.

Authors:  Anne J Ridley
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

6.  A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.

Authors:  J Yu; V Baron; D Mercola; T Mustelin; E D Adamson
Journal:  Cell Death Differ       Date:  2006-09-22       Impact factor: 15.828

7.  EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Authors:  Roi Avraham; Aldema Sas-Chen; Ohad Manor; Israel Steinfeld; Reut Shalgi; Gabi Tarcic; Noa Bossel; Amit Zeisel; Ido Amit; Yaara Zwang; Espen Enerly; Hege G Russnes; Francesca Biagioni; Marcella Mottolese; Sabrina Strano; Giovanni Blandino; Anne-Lise Børresen-Dale; Yitzhak Pilpel; Zohar Yakhini; Eran Segal; Yosef Yarden
Journal:  Sci Signal       Date:  2010-06-01       Impact factor: 8.192

8.  Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis.

Authors:  Shuta Ishibe; Dominique Joly; Xiaolei Zhu; Lloyd G Cantley
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

9.  Cten is targeted by Kras signalling to regulate cell motility in the colon and pancreas.

Authors:  Saleh Al-Ghamdi; Abdulkader Albasri; Julien Cachat; Salih Ibrahem; Belal A Muhammad; Darryl Jackson; Abdolrahman S Nateri; Karin B Kindle; Mohammad Ilyas
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts.

Authors:  Go Totsukawa; Yue Wu; Yasuharu Sasaki; David J Hartshorne; Yoshihiko Yamakita; Shigeko Yamashiro; Fumio Matsumura
Journal:  J Cell Biol       Date:  2004-02-02       Impact factor: 10.539

View more
  8 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.

Authors:  Andrew S McNeal; Kevin Liu; Vihang Nakhate; Christopher A Natale; Elizabeth K Duperret; Brian C Capell; Tzvete Dentchev; Shelley L Berger; Meenhard Herlyn; John T Seykora; Todd W Ridky
Journal:  Cancer Discov       Date:  2015-07-16       Impact factor: 39.397

Review 3.  Steering tumor progression through the transcriptional response to growth factors and stroma.

Authors:  Morris E Feldman; Yosef Yarden
Journal:  FEBS Lett       Date:  2014-05-27       Impact factor: 4.124

4.  A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells.

Authors:  Nathalie Sakakini; Laurent Turchi; Aurélie Bergon; Hélène Holota; Samah Rekima; Fabrice Lopez; Philipe Paquis; Fabien Almairac; Denys Fontaine; Nathalie Baeza-Kallee; Ellen Van Obberghen-Schilling; Marie-Pierre Junier; Hervé Chneiweiss; Dominique Figarella-Branger; Fanny Burel-Vandenbos; Jean Imbert; Thierry Virolle
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

5.  Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.

Authors:  Maria Gagliardi; Mary Kathryn Pitner; Jihyun Park; Xuemei Xie; Hitomi Saso; Richard A Larson; Rachel M Sammons; Huiqin Chen; Caimiao Wei; Hiroko Masuda; Gaurav Chauhan; Kimie Kondo; Debu Tripathy; Naoto T Ueno; Kevin N Dalby; Bisrat G Debeb; Chandra Bartholomeusz
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

6.  LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway.

Authors:  Yoolhee Yang; Hyunju Choi; Mira Seon; Daeho Cho; Sa Ik Bang
Journal:  Stem Cell Res Ther       Date:  2016-04-19       Impact factor: 6.832

7.  Transcriptome study and identification of potential marker genes related to the stable expression of recombinant proteins in CHO clones.

Authors:  Uros Jamnikar; Petra Nikolic; Ales Belic; Marjanca Blas; Dominik Gaser; Andrej Francky; Holger Laux; Andrej Blejec; Spela Baebler; Kristina Gruden
Journal:  BMC Biotechnol       Date:  2015-10-23       Impact factor: 2.563

8.  CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.

Authors:  Q Tu; J Hao; X Zhou; L Yan; H Dai; B Sun; D Yang; S An; L Lv; B Jiao; C Chen; R Lai; P Shi; X Zhao
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.